Discontinued — last reported Q4 '24
Corporate Segment — Depreciation
Labcorp Holdings Corporate Segment — Depreciation remained flat by 0.0% to $1.38M in Q4 2024 compared to the prior quarter. Year-over-year, this metric declined by 38.2%, from $2.23M to $1.38M. Over 3 years (FY 2021 to FY 2024), Corporate Segment — Depreciation shows an upward trend with a 28.4% CAGR.
Analysis
How to read this metric
An increase suggests higher investment in corporate infrastructure or assets, whereas a decrease may indicate aging assets or reduced capital investment at the corporate level.
Detailed definition
This metric measures the systematic allocation of the cost of tangible assets held at the corporate level over their use...
Peer comparison
Similar to other large-scale healthcare providers, depreciation at the corporate level is generally low compared to segment-specific depreciation, reflecting the centralized nature of administrative assets.
lh_segment_corporate_segment_depreciationHistorical Data
| FY'21 | FY'22 | FY'23 | FY'24 | |
|---|---|---|---|---|
| Value | $2.60M | $3.70M | $8.90M | $5.50M |
| YoY Change | — | +42.3% | +140.5% | -38.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's corporate segment — depreciation?
- Labcorp Holdings (LH) reported corporate segment — depreciation of $1.38M in Q4 2024.
- How has Labcorp Holdings's corporate segment — depreciation changed year-over-year?
- Labcorp Holdings's corporate segment — depreciation decreased by 38.2% year-over-year, from $2.23M to $1.38M.
- What is the long-term trend for Labcorp Holdings's corporate segment — depreciation?
- Over 3 years (2021 to 2024), Labcorp Holdings's corporate segment — depreciation has grown at a 28.4% compound annual growth rate (CAGR), from $2.60M to $5.50M.
- What does corporate segment — depreciation mean?
- The portion of corporate-level asset costs recognized as an expense during the reporting period.